Our passion for quality and attention to details is evident in the time. The manufacturing and quality are licensed and supervised by Bolise Co., Ltd.
Product name:BN 83495
CAS:288628-05-7
Description:BN 83495, a first in class steroid sulfatase inhibitor, is tested in a phase I trial in the treatment of postmenopausal women with breast cancer.This press release contains forward-looking statements based upon GTx's current expectations. Forward-looking statements involve risks and uncertainties.
This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.For more information OR other products. Please contact us by Email, Tel, Fax or Send online enquiry. We will reply you as soon as possible.
1. Email: sales@chemicalspharm.com
2. Tel: +86 592 5365868
